MPE, in collaboration with other patient organisations, is conducting a project to analyse legal agreements of pharmaceutical companies with patient advocates. The project will make suggestions for simpler, more understandable agreements that would sufficiently reflect and protect the interests of both parties. Latest newsMyeloma Patients Europe appoints joint CEOsMarch 27, 2023Happy anniversary AMILO!March 8, 2023Job offer – Medical and Scientific officerMarch 1, 2023Daratumumab approved for first line treatment in IsraelJanuary 30, 2023
